ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Lung transplantation"

  • 2018 American Transplant Congress

    Increase in Potentially Resistant Non-Aspergillus Molds Isolated in Lung Transplant Recipients after Voriconazole and Posaconazole Prophylaxis

    M. Fung,1 J. Greenland,2,3 S. Hays,2 J. Singer,2 J. Golden,2 P. Chin-Hong.1

    1Infectious Diseases, University of California San Francisco, San Francisco, CA; 2Pulmonary and Critical Care, University of California San Francisco, San Francisco, CA.

    Background: Lung transplant recipients are at higher risk for invasive fungal infections compared to other solid organs transplant patients. Antifungal prophylaxis with mold-active azoles has…
  • 2018 American Transplant Congress

    NK Cells with a Lung-Resident Phenotype Represent the Most Prominent Donor Passenger Leukocyte Subset after Clinical Lung Transplantation

    C. Falk,1 R. BellmasSanz,1 B. Wiegmann,2 A-.M. Hitz,1 K. Bläsing,1 C. Neudörfl,1 I. Tudorache,2 C. Kühn,2 M. Avsar,2 A. Haverich,2 G. Warnecke.2

    1Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Germany; 2Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.

    ObjectivesDonor passenger leukocytes in peripheral blood of recipients after lung transplantation have been described long time ago. However, kinetics, distribution of T vs. NK cells,…
  • 2018 American Transplant Congress

    Primary Oral Vancomycin Prophylaxis Reduces the Incidence of Clostridium difficile Infection among Lung Transplant Recipients

    V. Bajrovic, K. Brizendine.

    Cleveland Clinic Foundation, Cleveland, OH.

    Purpose: To determine the efficacy of primary oral vancomycin prophylaxis in reducing the incidence of Clostridium difficile infection (CDI) in the early post-op period among…
  • 2018 American Transplant Congress

    Prospective Trial Using Pulmonary Rehabilitation to Treat Frailty

    C. Kennedy,1 P. Novotny,2 E. Stevens,1 J. Kirsch,3 J. Garrett,1 N. LeBrasseur,4 R. Benzo.1

    1Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN; 2Health Sciences Research, Mayo Clinic, Rochester, MN; 3Clinical and Health Psychology, University of FL, Gainesville, FL; 4Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN.

    Background: Frailty is a novel risk factor to potential lung transplant candidates and recipients associated with excess morbidity and mortality. Limited data is available on…
  • 2018 American Transplant Congress

    CXCR4 Inhibition Improves Donor Leukocyte Depletion during Ex Vivo Lung Perfusion

    R. Davis, Q. Gao, J. Yerxa, M. Daneshmand, J. Haney, J. Klapper, M. Hartwig, A. Barbas.

    Surgery, Duke University, Durham, NC.

    Background: Ex vivo lung perfusion (EVLP) has emerged as a modern preservation technique, developed to evaluate candidate donor lungs in a normothermic and metabolically active…
  • 2018 American Transplant Congress

    Gastroparesis after Lung Transplantation: A Single-Center Experience

    S. Biswas Roy,1 M. Davis,2 F. Rodriguez,3 R. Serrone,4 P. Kang,5 T. Ipsen,6 M. Smith,7 R. Bremner,7 J. Huang,7 J. Huang.7

    1St. Joseph's Hospital and Medical Center, Phoenix, AZ; 2University of Arizona College of Medicine, Phoenix, AZ; 3Grand Canyon University, Phoenix, AZ; 4St. Joseph's Hospital and Medical Center, Phoenix, AZ; 5University of Arizona College of Public Health, Phoenix, AZ; 6Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ; 7Norton Thoracic Institue, St. Joseph's Hospital and Medical Center, Phoenix, AZ.

    Objective: Gastroparesis (GP), common in patients undergoing lung transplantation (LTx) for end-stage lung disease, can affect quality of life and absorbency of immunosuppressants. In this…
  • 2018 American Transplant Congress

    Circulating Exosomes with Lung Self-Antigens, Kα1Tubulin and Collagen V, and Immune Regulatory Proteins in Lung Transplant Recipient with Primary Graft Dysfunction

    M. Sharma, S. Biswas Roy, R. Walia, A. Omar, R. Bremner, M. Smith, T. Mohanakumar.

    Norton Thoracic Institute, St. Joseph's Hospital & Medical Center, Phoenix.

    Background: Circulating exosomes isolated from lung transplant recipients (LTxRs) with acute or chronic rejection contains lung self-antigens (SAgs), K alpha 1 tubulin (Kα1T) and collagen…
  • 2018 American Transplant Congress

    Most Pediatric Transplant Centers Are Underperforming and in Proximity to Higher Volume Centers

    T. Nichols, A. Rana, J. Goss.

    Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX.

    Purpose. Many research studies have shown that low case volume has been associated with worse survival outcomes in each type of pediatric solid organ transplant.…
  • 2018 American Transplant Congress

    Disparate Risk Factors for Early and Late Death Impact Survival after Lung Transplant

    C. Lehr, E. Blackstone, K. McCurry, L. Thuita, W. Tsuang, M. Valapour.

    Cleveland Clinic, Cleveland, OH.

    Purpose: After implementation of the lung allocation score, there has been improvement in one- and three-year survival but not in five-year survival after lung transplant…
  • 2018 American Transplant Congress

    T-bet and STAT6 Double Deficiency Favors IL-17 Immunity after Lung Transplantation

    F. Liang,1 R. Chen,1 Q. Chen,2 J. Ochando,3 Y. Ding,1 J. Xu.1

    1Department of Immunology, Capital Medical University, Beijing, China; 2Department of Thoracic Surgery, Chaoyang Hospital, Beijing, China; 3Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.

    Background: The long-term success of lung transplantation is mainly limited by the development of obliterative bronchiolitis (OB) in which IL-17 plays a critical role. Direct…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 42
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences